KRAS p, G12c Mutated /Advanced Metastatic NSCLC
1 clinical trials · Condition
◉ Watch KRAS p, G12c Mutated /Advanced Metastatic NSCLC
| Record | Firm | Date |
|---|---|---|
| Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). (NCT04303780) | Amgen | 2020-06-04 |
Track KRAS p, G12c Mutated /Advanced Metastatic NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.